Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "US Migraine Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive insights into Migraine pipeline products, Migraine epidemiology, Migraine market valuations and forecast, Migraine drugs sales and competitive landscape in the US.
The research is classified into seven sections - Migraine treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope
- Migraine pipeline: Find out the products in clinical trials for the treatment of Migraine by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Migraine epidemiology: Find out the number of patients diagnosed (prevalence) with Migraine in the US
- Migraine drugs: Identify key products marketed and prescribed for Migraine in the US, including trade name, molecule name, and company
- Migraine drugs sales: Find out the sales revenues of Migraine drugs in the US
- Migraine market valuations: Find out the market size for Migraine drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025
- Migraine drugs market share: Find out the market shares for key Migraine drugs in the US
Benefits of this Research
- Support monitoring and reporting national Migraine market analysis and sales trends
- Track competitor drugs sales and market share in the US Migraine market
- Track competitive developments in Migraine market and present key issues and learnings
- Synthesize insights for Migraine market and products to drive business performance
- Answer key business questions about the Migraine market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Migraine products
- Supports decision making in R&D to long term marketing strategies
Key Topics Covered
1) Migraine Treatments
2) Migraine Pipeline
3) US Migraine Epidemiology
4) Marketed Drugs for Migraine in US
5) US Migraine Market Size and Forecast
6) US Migraine Products Sales and Forecast
7) US Migraine Market Competitive Landscape
8) Methodology
List of Tables
1. Migraine Phase 3 Clinical Trials, 2020
2. Migraine Phase 2 Clinical Trials, 2020
3. Migraine Phase 1 Clinical Trials, 2020
4. Migraine Epidemiology, US, 2016-2025
5. Marketed Drugs for Migraine, US, 2019
6. Migraine Market Size and Forecast ($), US, 2016-2025
7. Migraine Product Sales ($), US, 2016-2025
List of Figures
1. Migraine Epidemiology, US, 2016-2025
2. Migraine Market Size and Forecast ($), US, 2016-2025
3. Migraine Products Market Share (%), US, 2019
For more information about this report visit https://www.researchandmarkets.com/r/bjklpu
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900